À¶Ý®ÊÓÆµ

J&J Unit Can't Shake $442M Loss In Catheter Antitrust Suit

By Bryan Koenig ( August 28, 2025, 5:52 PM EDT) -- A California federal judge has refused to upend the $442 million trial loss of Johnson & Johnson's Biosense Webster health tech unit to Innovative Health, finding the jury was presented with sufficient evidence to fault Biosense for conditioning product support for its cardiac mapping systems on the purchase of cardiac catheters....

À¶Ý®ÊÓÆµ is on it, so you are, too.

A À¶Ý®ÊÓÆµ subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A À¶Ý®ÊÓÆµ subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience À¶Ý®ÊÓÆµ today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login